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ABSTRACT
Streptococcus canis is a zoonotic agent that causes serious invasive diseases in domestic animals
and humans, but knowledge about its pathogenic potential and underlying virulence mechanisms
is limited. Here, we report on the ability of certain S. canis isolates to form large bacterial
aggregates when grown in liquid broth. Bacterial aggregation was attributed to the presence
and the self-binding activity of SCM, the M protein of S. canis, as evaluated by bacterial sedi-
mentation assays, immunofluorescence- and electron microscopic approaches. Using a variety of
truncated recombinant SCM fragments, we demonstrated that homophilic SCM interactions occur
via the N-terminal, but not the C-terminal part, of the mature M protein. Interestingly, when
incubated in human plasma, SCM forms soluble protein complexes comprising its known ligands,
immunoglobulin G (IgG) and plasminogen (Plg). Co-incubation studies with purified host proteins
revealed that SCM-mediated complex formation is based on the interaction of SCM with itself and
with IgG, but not with Plg or fibrinogen (Fbg), well-established constituents of M protein-
mediated protein complexes in human-associated streptococci. Notably, these soluble, SCM-
mediated plasma complexes harbored complement factor C1q, which can induce complement
breakdown in the periphery and therefore represent another immune evasion mechanism of SCM.
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Streptococcus canis is a frequent colonizer of mucosal
surfaces and the skin of dogs and cats, and occasionally
identified in various other host species such as cows,
rats, minks, mice, rabbits, and foxes [1–6]. As an
opportunistic pathogen, S. canis infections generally
lead to local and self-limiting alterations of skin and
mucosa, but in some cases can proceed to severe and
life-threatening diseases, such as streptococcal toxic
shock-like syndrome (STSLS), necrotizing fasciitis
(NF), meningitis and septicemia [7–10]. S. canis can
be transmitted among different host species suggesting
a certain zoonotic potential [11–16].
Streptococcal M proteins are important virulence fac-
tors that confer anti-phagocytic properties, but may also
contribute to the development of post-streptococcal
(autoimmune) sequelae [17,18]. S. canis was long consid-
ered to be “M protein negative”, since very few epidemio-
logical studies reported about the identification of emm-
typeable S. canis isolates [19,20]. However, we recently
identified an open reading frame in a zoonotic strain of
S. canis, which although not typeable according to the
emm-typing scheme released by the Centers of Disease
Control and Prevention (CDC), encoded a protein that
shared important characteristics of
streptococcal M proteins. We named this protein SCM
for S. canis M protein [21]. SCM is a surface-attached,
fibrillar protein which is dimerized under physiological
conditions. Its anti-phagocytic activity is based on its par-
ticular capability to interact with itself (i) directly in
a homophilic manner and (ii) indirectly using the host-
derived zymogen plasminogen as a bridging molecule [22].
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Furthermore, we recently described how SCM binds
immunoglobulin G (IgG) in a non-opsonic manner (via
the constant IgG-Fc domain) and found that this interac-
tion prevents the deposition of C1q, a primary component
of the classical complement activation pathway, on the
bacterial surface [23].
The present manuscript describes the molecular
mechanisms that underlie the self-binding capability
of SCM and its consequences for the pathogenesis of
S. canis. In particular, we demonstrate that SCM alone,
when expressed on the bacterial surface, is sufficient for
the generation of large bacterial aggregates. Bacterial
aggregation is a common immune evasion mechanism
against phagocytic killing and is usually mediated by
bacterial surface proteins [24–27]. In other streptococci,
bacterial self-aggregation has been attributed to M-
and M-like proteins [28], but whether SCM,
the M protein of S. canis, also induces bacterial clump-
ing has not been previously investigated.
Lastly, we show that the soluble form of SCM leads
to the formation of multimeric protein complexes upon
incubation in human plasma. Homophilic SCM-SCM-
interactions and concurrent IgG-binding activity are
required for protein complex formation. Interestingly,
and in contrast to surface-attached SCM [23], the inter-
action between SCM and IgG in complex enables C1q
sequestration and may represent a virulence mechan-
ism to evade complement-mediated opsonization.
Results
SCM mediates bacterial self-aggregation
SCM-positive (SCM+) S. canis strain G361, its isogenic
SCM-targeted insertional mutant (G361Δscm), and natu-
rally occurring SCM-negative (SCM−) S. canis isolate G2
were incubated overnight in liquid broth. As depicted in
Figure 1(a,c), two different phenotypes were observed:
whereas SCM-negative strains G2 and G361Δscm grew as
homogenous suspensions, broth cultures inoculated with
SCM+ isolate G361 showed bacterial sedimentation at the
bottom of the test tube and an almost clear supernatant.
Re-suspension of the bacterial sediment of strain G361 was
followed by an immediate, time-dependent re-
sedimentation (Figure 1(b,d), squares). In contrast, neither
shaking the homogenous cultures of the SCM− strains G2
and G361Δscm led to bacterial sedimentation nor to the
clearance of the culture supernatants (Figure 1(b,d); cir-
cles). To test, whether SCMwas not only necessary but also
sufficient to promote sedimentation in liquid broth, we
generated an SCM-expressing Streptococcus gordonii
(SGO-SCM) strain by heterologous gene expression. As
predicted, sedimentation experiments depicted in Figure
S1 demonstrated an aggregative phenotype of SCM+
S. gordonii, whereas the SCM− parental strain (SGO)
grew homogenously in liquid broth.
To visualize bacterial aggregation, we conducted
both, field emission scanning electron microscopy
(FESEM) and confocal immunofluorescence micro-
scopy (IF). Consistent with results obtained in the
sedimentation assays, we found large bacterial aggre-
gates of SCM+ strain G361 (Figure 2, Figure S2) that
were entirely absent in bacterial cultures of strains
lacking SCM (Figure 2). Notably, single bacteria in
the large aggregates of strain G361 were decorated
with IgG; no such binding was seen in the SCM− strain
G2 and the isogenic SCM-targeted mutant G361Δscm
(Figure 2). These results corroborate the role of SCM as
the only IgG-binding receptor of S. canis [23].
The N-terminal part of SCM mediates homophilic
protein interactions
Since SCM self-interactions are reported [22], we probed
the role of this phenomenon in more detail. First, we
conducted binding inhibition studies incubating strain
SCM+ G361 with iodinated recombinant SCM and differ-
ent truncated, non-labelled SCM fragments (Figure 3(a)).
In the absence of unlabelled protein, the SCM binding
capacity of strain G361 was determined to be 24.1% ±
2.9%. Supplementation with 5 µg non-labelled WT SCM
considerably decreased binding to 4.4% ± 0.8%. A similar
reduction was observed using fragment N-225 comprising
the first 225 amino acids of the mature SCM protein (6.8%
± 0.9%). In contrast, using the C-terminal fragment C-226,
a binding capacity of 17.3% ± 1.5%was detected which was
similar to themature SCMprotein. To verify these data, we
iodinated truncated SCM fragments N-225 and C-226, and
incubated them with SCM+ strain G361 (Figure 3(b)). As
predicted, the C-terminal fragment C-226 exhibited only
marginal affinity to strain G361, whereas a strong interac-
tion was detected using fragment N-225 (Figure 3(b)).
To quantify the self-interaction of SCM, we performed
surface plasmon resonance analysis using theBiacore® T200
system. Recombinant SCM was immobilized on a CM5
sensor chip as a ligand and mature WT as well as different
truncated SCM fragments were applied as analytes in
a series of concentrations (1.5–50.0 µg/ml). The sensor-
grams for SCM-WT, N-225, and KO173225 showed spe-
cific and dose-dependent binding to SCM, whereas no
binding was detected for the C-terminal fragment C-226
(Figure 3(c)). The dissociation constant for the binding of
SCM to SCM was calculated from three independent
experiments as 4.12 × 10−6 Mol. Notably, a representative
dissociation constant of 5.85× 10−8Molwas determined for
the interaction between SCM and N-225. In summary,
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these data clearly show that SCM binds to itself via the
N-terminal part of the mature protein.
SCM leads to the formation of protein aggregates
in human plasma
The incubation of SCM with human plasma led to
formation of soluble protein aggregates, which were
subsequently harvested and separated by SDS-PAGE.
Several protein bands were detected with molecular
masses ranging from approximately 25 kDa to
160 kDa (Figure 4(a); SDS). We next applied western
blot analysis of SCM-mediated protein complexes from
human plasma to investigate their composition in more
detail. In a first step, we used antibodies against known
SCM ligands, such as Plg and IgG [21–23]. We were
also interested in knowing whether complement factor
C1q is incorporated into the protein aggregates, since
this might constitute another immune evasion pathway
for S. canis. For comparison, we included the fibrino-
gen binding protein of G streptococci (FOG),
an M protein of human-adapted S. dysgalactiae subsp.
equisimilis (S. equisimilis), which forms protein aggre-
gates upon co-incubation with human plasma [29]. As
depicted in Figure 4(a), both SCM (S) and protein FOG
(F) led to complex formation upon incubation in
human plasma as demonstrated by SDS-PAGE (SDS).
In western blot analysis, a specific band of approxi-
mately 92 kDa was observed for SCM- (S, asterisk),
but not for FOG-mediated protein complexes (F),
when antibodies directed against human Plg (α-Plg)
were used. Because of the intrinsic IgG binding cap-
ability of SCM [23] and FOG [30], protein bands with
molecular masses of approximately 160 kDa (S) and
66 kDa (F) appeared, resulting from the non-opsonic
interaction between both M proteins and the secondary
antibody. To verify the presence of IgG molecules in
the protein complexes, we used a secondary antibody
against human IgG (α-IgG) that was raised in goats and
a
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Figure 1. Analysis of streptococcal aggregation. (a) S. canis strain G2 (SCM−) and G361 (SCM+) were grown overnight at 37°C in TSB.
The photograph shows bacterial sedimentation. (b) Quantification of the sedimentation rate of the bacterial cultures shown in (a) by
measuring the optical density at 600 nm at the indicated time points. The results present mean and standard deviation of
a representative experiment done in triplicates. The experiments were repeated three times. (c) S. canis strain G361 wildtype
(G361) and the isogenic scm-targeted insertional mutant (G361Δscm) were grown overnight at 37°C in TSB. The photograph shows
bacterial sedimentation. (d) Quantification of the sedimentation rate of the bacterial cultures shown in (c) by measuring the optical
density at 600 nm at the indicated time points. The results present mean and standard deviation of a representative experiment
done in triplicates. The experiments were repeated three times.































































Figure 2. Microscopic analysis of streptococcal aggregation. (a) Scanning electron microscopic visualization of S. canis strain G2 and G361
from overnight cultures demonstrating bacterial aggregation of the SCM+ strain G361. Scale bars represent 10 µm left column and 5 µm right
column. (b) Confocal microscopic analysis of bacterial aggregation and IgG binding. S. canis strain G361 and G2 were grown overnight at 37°C
in TSB. Bacteria were allowed to adhere to poly-L-lysin-coated ibidi-slides, fixed and incubated with Alexa-488-conjugated rabbit (rb) IgG
(cyan). Bacterial DNA/RNA was stained with ethidium homodimer-1 (red). Bacterial aggregation was visualized by confocal microscopy.
Representative maximum intensity projections of deconvolved confocal z-stacks from 2 independent experiments are shown. Scale bar
represents 10 µm. (c) Scanning electron microscopic visualization of S. canis strain G361wt and G361Δscm from overnight cultures
demonstrating bacterial aggregation of the SCM+ strain G361wt. Scale bars represent 10 µm left column and 1 µm right column. (d)
Confocal microscopic analysis of bacterial aggregation and IgG binding. S. canis strain G361wt and G361Δscm from overnight cultures
generated and stained as described in (b). Alexa-488-conjugated rabbit (rb) IgG is shown in cyan and bacterial DNA/RNA stainedwith ethidium
homodimer-1 is shown in red. Representative maximum intensity projections of deconvolved confocal z-stacks from 2 independent
experiments are shown. Scale bar represents 10 µm.
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therefore not recognized by the IgG-binding regions of
SCM and FOG [23,30]. This antibody detected the
presence of IgG heavy and light chains in both, SCM-
and FOG-mediated protein complexes. However,
whether IgG was necessary for complex formation in
FOG-derived protein aggregates (as shown for SCM),
could not be finally clarified. Interestingly, C1q, an IgG
ligand and an early component of the classical comple-
ment pathway was detected only in SCM-, but not in
FOG-mediated protein complexes (α-C1q).
To investigate the nature of the SCM-mediated com-
plex formation in more detail, we co-incubated SCMwith
its ligands IgG and Plg as well as fibrinogen (Fbg), since
Fbg promotes complex formation with M proteins from
S. pyogenes (Group A Streptococcus, GAS) and
S. equisimilis [29,31]. As depicted in Figure 4(b), neither
incubation of SCM with plasminogen (lane 6) nor incu-
bation of SCM with Fbg (lane 9) or Plg and Fbg (lane 7)
resulted in protein precipitation. However, co-incubation
of SCM with IgG (lane 2) and, in particular, with the
constant crystallisable part (Fc) of the IgG molecule
(IgG-Fc), was not only sufficient but also necessary to
facilitate protein aggregate formation (Figure S3).
Notably, supplementation of additional plasma proteins,










































































Figure 3. SCM interacts with itself via its N-terminus. (a) The SCM+ S. canis strain G361 was incubated with iodinated full-length SCM
either without (w/o) or with pre-incubation with 1 µM non-iodinated SCM, N-225 or C-226, respectively. (b) S. canis G 361 was co-
incubated with iodinated SCM and its derivatives C-226 and N-225, respectively. Results are depicted as mean and SD of percentage
binding of totally used iodinated protein. (c) Interactions of soluble SCM-WT and its truncated fragments KO173225, N-225 and
C-226, respectively, with immobilized SCM-WT were analyzed by surface plasmon resonance spectroscopy. Representative sensor-
grams of three independent experiments show a dose-dependent binding of SCM-WT, KO173225 and N-225. No binding was
observed for the C-terminal fragment C-226. The association and dissociation was observed, each of 300 s. Values of the control flow
cells were subtracted from each sensorgram. The KD value is indicated for the interaction between SCM and SCM. A representative KD
value was calculated for the interaction between N-225 and SCM.
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Figure 4. SCM-mediated complex formation is IgG-dependent. (a) Recombinant full-length SCM protein from strain G361 was added to
human plasma (1:10 diluted) and incubated for 4 h at 37°C. After precipitation, protein aggregates were carefully washed with PBS,
resuspended in Laemmli buffer and separated on a 10% SDS gel (SDS) or blotted onto a PVDF membrane and applied for western blot
analysis using antibodies directed against plasminogen (α-Plg), IgG (α-IgG), and C1q (α-C1q). The three subunits of C1q (a, b, c) are indicated.
(b) Recombinant WT-SCM was co-incubated with different host proteins alone or in combination and tested for complex formation (black
numbers). Human IgG (1), plasminogen (5), fibrinogen (8) and recombinant SCM (10) served as protein quality controls (red numbers). (c)
Increasing amounts of recombinant SCM protein (1 µg – 80 µg) were co-incubated with 20 µg human IgG. The resulting protein aggregates
were analysed by SDS-PAGE. 20 µg of the truncated SCM fragment lacking the IgG binding region (KO173225) served as a control. 0, 20 µg IgG
was incubatedwithout SCM supplementation. (d) Recombinant full-length protein SCMand its derivatives N-173, N-225, KO173225, C-173 and
C-226, respectively, were incubated with 1:10-diluted human plasma. Complex formation was monitored qualitatively by SDS-PAGE. (e)
Schematic representation of the truncated fragments used in this study and their ability to bind IgG, SCM and to induce complex formation.
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such as Plg and/or Fbg did not lead to inhibitory effects on
complex formation (Figure 4(b), lanes 3, 4, 11). Rather,
Plg (a further ligand of SCM), co-precipitated with SCM
and IgG (Figure 4(b), lanes 3 and 11).
We next incubated a constant amount of IgG (20 µg)
with different amounts of SCM (1, 10, 20, 40, and
80 µg) and analysed complex formation qualitatively
by SDS-PAGE. As depicted in Figure 4(c), increasing
concentrations of SCM concomitantly led to an
increase in recruited IgG, suggesting that complex for-
mation follows a strict stoichiometrical ratio. Notably,
similar results were observed when different amounts
of SCM were incubated with human plasma (Figure
S4). Finally, protein aggregation assays were performed
using different truncated SCM fragments with either
IgG- (C-173), SCM- (KO173225), IgG- and SCM-
(N-225) or neither IgG- nor SCM- (C-226) binding
capabilities (Figure 4(d)). As expected, complex forma-
tion was only observed for the mature WT SCM and
the N-terminal fragment N-225 that resembles both,
SCM and IgG binding capability. Truncated fragments
harbouring only SCM- or only IgG-binding activity did
not form SCM-IgG protein complexes. An overview
summarizing these results is given in Figure 4(e).
Discussion
M- and M-like proteins constitute a large family of strep-
tococcal surface proteins and numerous publications that
summarize the current literature about their distribution
and their function are available. One of the most impor-
tant features of M- and M-like proteins is their anti-
phagocytic property, which by definition has been con-
firmed in M proteins, but only assumed for M-like pro-
teins [32]. Themechanisms by whichM proteins facilitate
anti-phagocytosis are versatile and include interactions
with the host immune system (e.g. binding to plasma
and extracellular matrix proteins, reviewed in [33,34])
but also the ability to interact with itself (homophilic
protein interactions). Knowledge about the molecular
mechanisms of the latter are scant and prompted us to
conduct the present study.
We recently identified SCM, the M protein in
S. canis, and confirmed its anti-phagocytic properties
mediated by plasma protein binding [21–23]. SCM
forms homophilic protein interactions and the supple-
mentation of purified SCM protein to SCM-deficient
S. canis significantly increased bacterial survival in co-
incubation experiments with purified polymorphonuc-
lear neutrophils (PMNs). In line with this, Frick and
colleagues reported about homophilic protein interac-
tions of the surface-associated proteins Protein H and
M1 of GAS that led to bacterial aggregation and
facilitated anti-phagocytosis by particle enlargement
[28]. Similarly, we observed the formation of large
bacterial aggregates in S. canis liquid cultures and
demonstrated that SCM alone is not only sufficient
but also necessary for this particular phenotype
(Figures 1 and 2, Figures S1 and S2). However, whether
or not bacterial aggregation is also important for
S. canis to colonize the mucosal surfaces of the host
remains unknown. Frick et al. found that GAS adhere
significantly better to human epithelial cells when clus-
tered in bacterial aggregates [28]. Caparon and collea-
gues proposed that bacterial aggregation on epithelial
surfaces precedes microcolony formation [35], a well-
established mechanisms of bacteria to establish them-
selves in hostile conditions.
Several streptococcal M- and M-like proteins are
liberated from the bacterial surface by proteolytic clea-
vage and lead to complex formation when incubated in
host plasma [36,37]. We have previously demonstrated
that SCM is also released from the surface of S. canis
[22], and the results of the present study show further
that it forms similar soluble protein aggregates in the
presence of host plasma. However, in contrast to M1
and FOG, co-incubation of SCM with fibrinogen did
not lead to the formation of soluble protein aggregates.
This finding is consistent with the lack of fibrinogen
binding capability of SCM-positive strain G361 and in
S. gordonii heterologously expressing SCM (Figure S5).
However, co-incubation of SCM with its ligand IgG led
to the formation of soluble protein aggregates (Figure 4
(b)). Notably, a strong IgG-binding capability alone is
not sufficient to induce complex formation, because
truncated C-terminal SCM fragments exhibiting even
stronger affinities for IgG [23], failed to induce protein
aggregation when co-incubated with IgG. In contrast,
N-terminal SCM fragments facilitate complex forma-
tion as long as they consist of the entire IgG-binding
region (Figure 4(d)). These observations suggest that
the generation of SCM-IgG complexes requires not
only a functional IgG-binding site (and, thus, IgG-
binding activity), but also the ability for SCM to inter-
act with itself. Furthermore, our results clearly indi-
cated that the region that mediates SCM self-binding
activity is located in the N-terminal part of the mature
protein. This conclusion is supported by the observa-
tion that (i), only the N-terminal fragment reduced the
binding of iodinated SCM to the surface of S. canis in
competition experiments, whereas the C-terminal part
of SCM did not (Figure 3(a)), and (ii) radiolabelled
SCM fragments showed only a strong back-binding
activity to the surface of S. canis for the N-terminal
SCM fragment, but not for C-226 (Figure 3(b)).
Notably, the back-binding activity of N-225 to the
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surface of G361 was more pronounced than of the
mature SCM protein, which was additionally confirmed
in SPR analysis (Figure 3(c)). The calculated dissocia-
tion constant of 5.85 × 10−8 Mol for the interaction
between SCM and N-225 exceeds the KD of the SCM-
SCM interaction (4.12 × 10−6 Mol) by approximately
two logs. The reason is unknown, but intra-molecular
structural differences between N- and C-terminal parts
of the entire M protein are likely to be involved [38].
Interestingly, Protein H of GAS interacts with itself via
a 18mer peptide region (designated AHP, for aggrega-
tive protein H peptide) located in the N-terminus [28].
AHP and similar peptide sequences were also identified
in a series of other M- and M-like proteins from GAS,
emphasizing the role of homophilic interactions in such
alpha helical proteins. However, in silico analysis of
AHP and the N-terminal part of SCM did not reveal
any significant sequence homologies, neither at geno-
mic nor protein levels (data not shown), suggesting the
existence of analogous binding sites and again stressing
the possibility of a convergent evolution of M-
and M-like proteins [39].
An important, unsolved question is the biological
role of protein complex formation. For the SCM
analogue Protein H, when immobilised on the bacter-
ial surface, interaction with IgG inhibits the deposi-
tion of C1q and C3, which led to a significantly
reduced complement-mediated opsonisation and
immune-cell-mediated killing of the bacteria. In con-
trast, the presence of C1q in M-protein-mediated IgG
complexes led to complement breakdown distant
from the bacterial surface, thus representing another
virulence trait of IgG-Fc receptor positive streptococci
[40]. We similarly observed an inhibition of C1q
deposition on SCM+ S. canis isolates [23] and
a sequestration of C1q in SCM-plasma complexes
(Figure 4) implicating that SCM is likewise involved
in the resistance against complement-mediated killing
by phagocytes. In addition to interference with com-
plement, Herwald and colleagues reported that
Protein M1 from GAS forms complexes with fibrino-
gen when added to human serum [41]. These protein
complexes, in turn, activate PMNs to release the
heparin binding protein that might ultimately lead
to vascular leakage, shock and multi-organ failure.
Notably, these clinical pictures are not pathognomo-
nic for systemic infections of human-restricted strep-
tococci, but are also found in cats suffering from
invasive S. canis infections [8,9,42–44].
In summary, we investigated the molecular mechan-
isms behind the aggregative phenotype of SCM+ S. canis
strains. We found that anti-phagocytic M protein SCM
mediates homophilic protein interactions that, when
immobilized on the bacterial surface, led to the formation
of large bacterial aggregates. In the presence of IgG, SCM
protein, which is liberated from the bacterial surface,
triggers the formation of soluble protein complexes com-
posed of various host-plasma proteins, including compo-
nents of the complement system. However, whether
bacterial aggregation and SCM-mediated complex forma-
tion impacts the outcome of mucosal colonization or
systemic dissemination in the pathogenesis of S. canis
infections remains unknown and awaits further
investigations.
Material and methods
Bacterial strains and growth conditions
The SCM-positive Streptococcus canis strain G361
(kindly provided by Dr. Mark van der Linden,
National Reference Centre for Streptococci, RWTH
Aachen, Aachen, Germany) was introduced in several
studies [6,21–23,45] and its genome was released only
recently [46]. G361 was isolated from a vaginal swab of
a 40-year-old woman. S. canis strain G361 is not type
able by the CDC emm-typing scheme. The isolation site
of strain G2 is unknown. S. gordonii heterologously
expressing SCM and its SCM-negative parental strain
was described earlier [21]. Bacteria were routinely
grown in tryptic soy broth (TSB) or Todd-Hewitt
broth (THB) at 37°C without shaking. In preparation
for electroporation, G361 was grown overnight in THB
supplemented with 0.6% glycine and subcultured into
50 ml of THB the following day. The resulting culture
was harvested at 1.5 hours of culture by centrifugation
(10 min at 3250 x g), washed once in 50 ml 0.625 M
sterile sucrose solution, and resuspended in 250 μl of
0.625 sucrose solution. Fifty μl aliquots were kept fro-
zen at −80ºC until needed. Escherichia coli strains were
cultivated in Luria-Bertani medium. Where indicated,
antibiotics were supplemented as follows. E. coli: ampi-
cillin (100 μg/ml), kanamycin (25 μg/ml), erythromycin
(Erm) (300 μg/ml); S. gordonii: Erm (1 μg/ml);
G361Δscm Erm (2 μg/ml).
Antibodies and reagents
Human IgG, papain-treated fragments of human IgG,
human plasminogen and fibrinogen were purchased
from Sigma. Polyclonal antibodies against human IgG
and plasminogen as well as HRP-conjugated anti-
human antibodies were purchased from Dako.
Antibodies directed against human C1q were from
Calbiochem. Ethidium homodimer-1 and the secondary
rabbit anti-mouse IgG Alexa Fluor 488 conjugated
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antibody (Cat#: A-11059; RRID: AB_2534106) were
obtained from Life Technologies. 16% formaldehyde
without methanol and CitiFluor™ CFM3 mounting med-
ium were obtained from Electron Microscopy Science.
Construction of the G361 scm targeted insertional
mutant
Targeted insertional mutagenesis of scm was performed as
previously described [47] using the pHY304 vector [48].
Briefly, an intragenic fragment from the scm gene was
amplified by PCR using the following primer pair:
TCTCAAGCTTTGACGGAGCAAG; TCTTCTAGATCA
GCTGTCAAGCG. PCR products were recovered by
T-A cloning in the vector pCR2.1-TOPO (Invitrogen) and
then were cloned by HindIII/XbaI digestion into the tem-
perature-sensitive vector pHY304. Three μg of the resultant
knockout plasmid was introduced into G361 by electro-
poration, and Erm-resistant transformants were identified
at the permissive temperature for plasmid replication
(30°C). Single-crossover Campbell-type chromosomal
insertion was selected by shifting to the nonpermissive
temperature (37°C) while maintaining Erm selection.
SCM phenotype was determined on Todd-Hewitt agar
(THA) plus 2 μg Erm at 37°C.
Cloning and expression of truncated SCM
fragments
Cloning and overexpression of recombinant SCM as
well as its truncated fragments was already introduced
earlier [21,23]. Briefly, based on the mature scm frag-
ment that was cloned into the Qiagen´s pQE30 expres-
sion vector, an inverse PCR technique was developed
that, based on the positioning of the oligonucleotides,
the generation of N-terminal, C-terminal and internal
deletion fragments. An overview about the truncated
SCM fragments that were used in the present paper are
given in Figure 4(e). Overexpression and purification of
histidine-tagged recombinant proteins were done
essentially as described by the manufacturer (Qiagen
ExpressionistTM System).
Protein aggregation assays, SDS-PAGE and western
blot analysis
Various amounts of recombinant FOG [30], SCM [21]
or its truncated fragments N-173, N-225, C173, C-226
and KO173225 [23], respectively, were incubated in
a 1:10 dilution (in PBS) of human plasma for 4 hours
at 37°C in a water bath. After centrifugation at
13,000 rpm, protein aggregates were washed two
times in 100 µl 0.1 M NaCl containing 0.5% (v/v)
Triton X-100 and finally resuspended in 20 µl
Laemmli buffer. Co-incubation of SCM with purified
proteins (IgG, Plg and Fbg, respectively) was carried
out in PBS containing 2% (v/v) Triton X-100. All pro-
tein suspensions were incubated for 1 h at room tem-
perature. Centrifugation steps and washing procedures
were as described above. In any case, protein complexes
were separated by a 10% reducing SDS gel. If indicated,
the resuspended protein complexes were subjected to
immunoblotting using the BioRad semidry system
essentially as described earlier [21]. Primary antibodies
against Plg, IgG and C1q, respectively, were used in the
following dilutions: α-Plg, 1:5000; α-IgG, 1:2000; α-
C1q, 1:1500. HRP-conjugated secondary antibodies
were used in a 1:3000 dilution. Peroxidase activity was
detected by chemoluminescence using 100 mM Tris
HCl, 1.25 mM 3-aminopthalhydrazide, 225 µM p-cou-
maric acid, and 0.01% H2O2 at pH 8.8 in water and
exposed to chemoluminescence films (Hyperfilm;
Amersham).
Field emission scanning electron microscopy
(FESEM)
Bacteria were fixed with 5% formaldehyde and 2%
glutaraldehyde in growth media, left overnight at 7°C,
and then washed with TE buffer (10 mM TRIS, 2mM
EDTA, pH 6.9). Samples were dehydrated in a graded
series of acetone (10, 30, 50, 70, 90, 100%) on ice for
10 min for each step. Samples in the 100% acetone step
were allowed to reach room temperature before another
change in 100% acetone. Samples were then subjected
to critical-point drying with liquid CO2 (CPD 030, Bal-
Tec,). Dried samples were coated with a gold/palladium
(80/20) film by sputter coating (SCD 500, Bal-Tec)
before examination in a field emission scanning elec-
tron microscope Zeiss Merlin using the Everhart
Thornley HESE2-detector and the inlens SE-detector
in a 25:75 ratio at an acceleration voltage of 5 kV.
Images were recorded with Zeiss SEMSmart V 5.05
and contrast and brightness were adjusted with Adobe
Photoshop CS5.
Immunofluorescence staining and confocal
microscopy
For confocal microscopy, 100 µl of bacterial overnight
culture was added into poly-L-lysine-coated µ-slide
8-well (ibidi) filled with 100 µl PBS for 30 min.
Subsequently, specimens were fixed with 3% formalde-
hyde for 15 min. Following washing with PBS samples
were incubated with rabbit anti-mouse Alexa Fluor 488-
conjugated IgGs in PBS/1% BSA/Tween 20 overnight at
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4°C. Bacterial RNA/DNA was stained with ethidium
homodimer-1 and samples were embedded in
CitiFluor™ CFM3 mounting medium. Mounted samples
were examined by confocal microscopy as described pre-
viously [49]. In brief, image stacks with a z-step size of
0.2 μmper plane were acquired using a 63 × /1.4 NAPlan-
Apochromat objective. The pinhole was set to 1 airy unit
and images were acquired in sequential imaging mode to
avoid bleed-through of fluorescence emission. Images
were deconvolved using Huygens® Essential 15.10
(Scientific Volume Imaging) and 3D-stacks are displayed
as maximum intensity projections (MIPs) and adjusted
identically for brightness and contrast in ImageJ/Fiji [50].
3D-rendering was done with ParaView v5.4
(Kitware Inc.).
Surface plasmon resonance spectrometry
The interaction of SCM-WT with itself as well as with
truncated fragments was analysed by surface plasmon
resonance spectroscopy using a Biacore T200 optical
biosensor (GE Healthcare). Therefore, recombinant
SCM-WT was immobilized on a carboxymethyl dex-
tran sensor chip (CM5) essentially as described pre-
viously [23]. SCM-WT, KO173225 and the C- and
N-terminal fragments N-225 and C-226, respectively,
were used as analytes in a concentration range of 1.56–
50 µg/ml. Binding analysis was performed in PBS con-
taining 0.05% Tween 20 at 25°C and a flow rate of
10 µl/min. Data were analysed using Biacore T200
evaluation software (version 2.0.1.1).
Radioactive labelling, binding and inhibition
studies
Iodination of fibrinogen, SCM and its truncated frag-
ments SCM-N225 and SCM-C226 was performed with
the chloramine T method as described earlier [51].
Binding and subsequent inhibition were carried out as
described elsewhere [21,23].
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